Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Soluble syndecan-1 (sCD138) as a prognostic factor independent of mutation status in patients with chronic lymphocytic leukemia.

International journal of laboratory hematology - 1 Feb 2009

Jilani I, Wei C, Bekele B N, Zhang Z J, Keating M, Wierda W, Ferrajoli A, Estrov Z, Kantarjian H, O'Brien S M, Giles F J, Albitar M

Abstract excerpt

Syndecan-1 (sCD138) is a transmembrane heparan sulfate-bearing proteoglycan expressed in epithelial cells as well as hematopoietic cells that demonstrate plasmacytoid differentiation. Higher levels of sCD138 correlate with poor outcome in myeloma. We examined the association of circulating sCD138 levels in plasma with clinical behavior in 104 patients with chronic lymphocytic leukemia. sCD138 levels were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Leukemia, Lymphocytic, Chronic, B-Cell

Share to Predictive Value of Tests

Share to Prognosis

Share to Solubility

Share to Syndecan-1

Source

Open in PubMed Open full text

Identifiers

PMID: 18190591
DOI: 10.1111/j.1751-553X.2007.01010.x
PMCID: PMC4163781

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Soluble syndecan-1 (sCD138) as a prognostic factor independent of mutation status in patients with chronic lymphocytic leukemia.PMID 18190591Read ↗

Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine.Semantic proximity Read ↗

Soluble CD138 serum levels are not associated with other poor prognostic markers in patients with B-chronic lymphocytic leukaemia.Semantic proximity Read ↗

Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic LeukemiaSemantic proximity Read ↗

CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.Semantic proximity Read ↗

Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.Semantic proximity Read ↗

Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression.Semantic proximity Read ↗

Syndecan-1 (CD138), Carcinomas and EMTSemantic proximity Read ↗

Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical Recurrence.Semantic proximity Read ↗

HS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognosesSemantic proximity Read ↗

Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.